Why Is Everyone Talking About Quidel Stock?
Given that making fast COVID-19 testing widely available will be a critical prerequisite for the safe reopening of the U.S. economy, it's no surprise that companies the manufacture those coronavirus tests are feeling the bright glare of investor attention. Quidel (NASDAQ: QDEL) specializes in the diagnosis and detection of diseases, offering tests with fast turnaround times at the point of care, and some of its big wins in the COVID-19 diagnostics space have investors buzzing about the stock.
In mid-March, Quidel became one of the first companies to receive an Emergency Use Authorization (EUA) from the Food and Drug Administration for a COVID-19 diagnostic test. That test uses molecular polymerase chain reaction (PCR) technology and requires the patient's sample to be sent to a certified testing laboratory for processing. But since then, Quidel has focused on rapid immunoassay COVID-19 tests that can be analyzed in clinics while patients wait for their results.
Image source: Getty Images.
Source Fool.com
